PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2020-07-26

Date Title Company
26-Jul-2020 Lynk Pharmaceuticals enters exclusive licensing agreements with Kobe University and with RIKEN Research Institute to develop RAS inhibitors with a novel MOA Lynk Pharmaceuticals